End-of-day quote
Taipei Exchange
18:00:00 2024-05-12 EDT
|
5-day change
|
1st Jan Change
|
90
TWD
|
-3.64%
|
|
-11.33%
|
+66.36%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,239
|
1,644
|
1,592
|
1,805
|
2,097
|
2,251
|
Enterprise Value (EV)
1 |
1,370
|
1,579
|
1,464
|
1,750
|
2,237
|
2,314
|
P/E ratio
|
11.2
x
|
8.72
x
|
14.5
x
|
9.41
x
|
11.9
x
|
8.3
x
|
Yield
|
6.25%
|
6.64%
|
4.84%
|
7.09%
|
5.56%
|
4.81%
|
Capitalization / Revenue
|
0.52
x
|
0.66
x
|
0.58
x
|
0.58
x
|
0.55
x
|
0.61
x
|
EV / Revenue
|
0.57
x
|
0.63
x
|
0.53
x
|
0.56
x
|
0.58
x
|
0.62
x
|
EV / EBITDA
|
4.67
x
|
5.78
x
|
4.74
x
|
4.29
x
|
5.19
x
|
6.51
x
|
EV / FCF
|
45.8
x
|
7.18
x
|
6.84
x
|
32.1
x
|
-80.9
x
|
30.8
x
|
FCF Yield
|
2.18%
|
13.9%
|
14.6%
|
3.11%
|
-1.24%
|
3.25%
|
Price to Book
|
1.07
x
|
1.31
x
|
1.27
x
|
1.28
x
|
1.52
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
41,609
|
41,045
|
38,553
|
41,303
|
41,609
|
41,609
|
Reference price
2 |
29.79
|
40.05
|
41.30
|
43.70
|
50.40
|
54.10
|
Announcement Date
|
19-04-01
|
20-03-31
|
21-03-30
|
22-03-31
|
23-03-31
|
24-03-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,395
|
2,498
|
2,753
|
3,121
|
3,823
|
3,702
|
EBITDA
1 |
293.4
|
273.1
|
308.8
|
407.6
|
430.9
|
355.2
|
EBIT
1 |
198.8
|
176.9
|
219.1
|
292.6
|
323.2
|
245
|
Operating Margin
|
8.3%
|
7.08%
|
7.96%
|
9.38%
|
8.45%
|
6.62%
|
Earnings before Tax (EBT)
1 |
273.5
|
347.2
|
322.2
|
431.8
|
460.2
|
486.3
|
Net income
1 |
110.6
|
190.4
|
121.7
|
191.1
|
175.3
|
271.5
|
Net margin
|
4.62%
|
7.62%
|
4.42%
|
6.12%
|
4.58%
|
7.33%
|
EPS
2 |
2.659
|
4.596
|
2.846
|
4.645
|
4.219
|
6.520
|
Free Cash Flow
1 |
29.92
|
220.1
|
214.2
|
54.47
|
-27.64
|
75.11
|
FCF margin
|
1.25%
|
8.81%
|
7.78%
|
1.75%
|
-0.72%
|
2.03%
|
FCF Conversion (EBITDA)
|
10.2%
|
80.6%
|
69.37%
|
13.36%
|
-
|
21.14%
|
FCF Conversion (Net income)
|
27.05%
|
115.59%
|
176.04%
|
28.51%
|
-
|
27.67%
|
Dividend per Share
2 |
1.862
|
2.660
|
2.000
|
3.100
|
2.800
|
2.600
|
Announcement Date
|
19-04-01
|
20-03-31
|
21-03-30
|
22-03-31
|
23-03-31
|
24-03-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
131
|
-
|
-
|
-
|
140
|
62.7
|
Net Cash position
1 |
-
|
64.8
|
128
|
54.6
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.4461
x
|
-
|
-
|
-
|
0.3239
x
|
0.1764
x
|
Free Cash Flow
1 |
29.9
|
220
|
214
|
54.5
|
-27.6
|
75.1
|
ROE (net income / shareholders' equity)
|
11.5%
|
14.3%
|
11.7%
|
15.3%
|
15.4%
|
16.3%
|
ROA (Net income/ Total Assets)
|
4.09%
|
3.29%
|
3.79%
|
4.6%
|
4.45%
|
3.07%
|
Assets
1 |
2,705
|
5,787
|
3,209
|
4,156
|
3,935
|
8,852
|
Book Value Per Share
2 |
27.80
|
30.50
|
32.60
|
34.20
|
33.10
|
39.70
|
Cash Flow per Share
2 |
5.230
|
8.290
|
11.30
|
13.00
|
15.80
|
17.20
|
Capex
1 |
107
|
43.1
|
33
|
101
|
145
|
284
|
Capex / Sales
|
4.48%
|
1.72%
|
1.2%
|
3.23%
|
3.78%
|
7.66%
|
Announcement Date
|
19-04-01
|
20-03-31
|
21-03-30
|
22-03-31
|
23-03-31
|
24-03-25
|
|
1st Jan change
|
Capi.
|
---|
| +66.36% | 115M | | +8.88% | 34.66B | | +15.40% | 7.98B | | +12.24% | 8.05B | | +25.80% | 5.71B | | -5.48% | 4.07B | | +11.93% | 3.66B | | +12.27% | 3.63B | | -10.54% | 2.7B | | -29.91% | 2.31B |
Testing & Measuring Equipment
|